Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)

NCT04823585 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Asthma, Aspirin-Induced
Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG: Mepolizumab
DRUG: Placebo

Sponsor

Helsinki University Central Hospital